Osimertinib related cardiotoxicity in patients with non-small cell lung cancer

被引：0
|
作者：
Mensah, Samuel Akaakole [1 ]
Alruwaili, Waleed [1 ]
Ahmad, Syed [1 ]
Patel, Brijesh [1 ]
Almubarak, Mohammed [1 ]
机构：
[1] West Virginia Univ, Morgantown, WV 26506 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20011
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Risk factors of osimertinib-related cardiotoxicity in non-small cell lung cancer
    Wang, Yunlong
    Deng, Xuan
    Qiu, Qinggui
    Wan, Mengchao
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [2] Cardiovascular safety of Osimertinib in non-small cell lung cancer patients
    Chavan, Ashish
    Shirsat, Aditi
    Chopade, Sunil
    Menon, Nandini
    Patil, Vijay
    Noronha, Vanita
    Gota, Vikram
    Prabhash, Kumar
    Nookala, Manjunath
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 161 - 162
  • [3] Osimertinib for the treatment of non-small cell lung cancer
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (02) : 225 - 231
  • [4] Pathological assessment of osimertinib-associated cardiotoxicity in EGFR-mutated non-small cell lung cancer patients
    Oka, T.
    Kamada, R.
    Kunimasa, K.
    Oboshi, M.
    Nishikawa, T.
    Yasui, T.
    Shioyama, W.
    Miyashita, Y.
    Koyama, T.
    Kumagai, T.
    Fujita, M.
    EUROPEAN HEART JOURNAL, 2020, 41 : 881 - 881
  • [5] Delayed cardiotoxicity following osimertinib therapy in non-small cell lung cancer: a unique case report
    Xu, Zhanwen
    Jia, Haiyan
    Yin, Xiaoping
    ANTI-CANCER DRUGS, 2024, 35 (06) : 556 - 558
  • [6] When Targeted Therapy Targets the Heart: Osimertinib-related Cardiotoxicity in EGFR Mutated Non-Small Cell Lung Cancer
    Martinez, F. J.
    Liu, R.
    Zhu, S.
    Sakoda, L.
    Goh, C.
    Ropko, V.
    Sarovar, V.
    Suga, M.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S198 - S198
  • [7] Osimertinib-Associated Cardiomyopathy In Patients With Non-Small Cell Lung Cancer
    Franquiz, Miguel J.
    Waliany, Sarah
    Xu, Audrey Yingwei
    Hnatiuk, Anna
    Wu, Sean M.
    Cheng, Paul
    Wakelee, Heather A.
    Neal, Joel
    Witteles, Ronald
    Zhu, Han
    JACC: CARDIOONCOLOGY, 2023, 5 (06): : 839 - 841
  • [8] Osimertinib rechallenge in advanced EGFR non-small cell lung cancer patients
    Uy, Natalie F.
    Tratt, Micah
    Eaton, Keith D.
    Santana-Davila, Rafael
    Baik, Christina S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] A systematic review of non-small cell lung cancer treatment-related cardiotoxicity
    Chan, Stefanie Ho Yi
    Khatib, Yasmin
    Webley, Sherael
    Layton, Deborah
    Salek, Sam
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 129 - 129
  • [10] Exposure-response modelling of osimertinib in patients with non-small cell lung cancer
    Johnson, Martin
    Lin, Yu-Wei
    Schmidt, Henning
    Sunnaker, Mikael
    Van Maanen, Eline
    Huang, Xiangning
    Rukazenkov, Yuri
    Tomkinson, Helen
    Vishwanathan, Karthick
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (12) : 3263 - 3276
12345